logo-loader

ValiRx puts convertible loan note facility with Yorkville to bed

Published: 15:22 27 Dec 2017 GMT

Bank roll
The company's issued share capital will comprise of 399mln shares on admission of the 25.2mln shares to YA II.

Cancer therapeutics specialist ValiRx Plc (LON:VAL) said its standby equity distribution agreement with Yorkville (YA) is now done and dusted.

YA elected to convert all remaining US$520,000 of its convertible loan notes from the second tranche of its loan facility into 25.2mln ValiRx shares at a conversion price of 1.5429p a share.

No further amounts on Tranche 2 of the convertible loan notes (CLNs) remain outstanding. As previously announced Tranches 1 and 3 have been fully repaid and so this is the final conversion under the CLN facility.  

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

1 hour, 47 minutes ago